- Home
- PBYI vs CTGO Comparison
PBYI vs CTGO Comparison
Compare PBYI & CTGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBYI
- CTGO
- Stock Information
- Founded
- PBYI 2010
- CTGO 2009
- Country
- PBYI United States
- CTGO United States
- Employees
- PBYI N/A
- CTGO N/A
- Industry
- PBYI Biotechnology: Pharmaceutical Preparations
- CTGO Precious Metals
- Sector
- PBYI Health Care
- CTGO Basic Materials
- Exchange
- PBYI Nasdaq
- CTGO Nasdaq
- Market Cap
- PBYI 138.4M
- CTGO 151.1M
- IPO Year
- PBYI N/A
- CTGO N/A
- Fundamental
- Price
- PBYI $2.91
- CTGO $13.76
- Analyst Decision
- PBYI Strong Buy
- CTGO Strong Buy
- Analyst Count
- PBYI 1
- CTGO 1
- Target Price
- PBYI $7.00
- CTGO $37.00
- AVG Volume (30 Days)
- PBYI 280.0K
- CTGO 130.7K
- Earning Date
- PBYI 05-08-2025
- CTGO 05-20-2025
- Dividend Yield
- PBYI N/A
- CTGO N/A
- EPS Growth
- PBYI 143.51
- CTGO N/A
- EPS
- PBYI 0.77
- CTGO N/A
- Revenue
- PBYI $232,668,000.00
- CTGO N/A
- Revenue This Year
- PBYI N/A
- CTGO N/A
- Revenue Next Year
- PBYI N/A
- CTGO N/A
- P/E Ratio
- PBYI $3.78
- CTGO N/A
- Revenue Growth
- PBYI 2.67
- CTGO N/A
- 52 Week Low
- PBYI $2.23
- CTGO $8.85
- 52 Week High
- PBYI $5.20
- CTGO $25.32
- Technical
- Relative Strength Index (RSI)
- PBYI 44.50
- CTGO 57.63
- Support Level
- PBYI $2.88
- CTGO $13.20
- Resistance Level
- PBYI $3.14
- CTGO $14.45
- Average True Range (ATR)
- PBYI 0.16
- CTGO 0.72
- MACD
- PBYI 0.00
- CTGO -0.12
- Stochastic Oscillator
- PBYI 11.36
- CTGO 28.50
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes innovative products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About CTGO Contango ORE Inc.
Contango Ore Inc operates in the United States. The company is engaged in the exploration of gold, silver, and copper ores in the State of Alaska. The company's focus is the exploration of a mineral lease with the Native Village of Tetlin whose governmental entity is the Tetlin Tribal Council for the exploration of minerals near Tok, Alaska. It has formed a joint venture to advance exploration of the Tetlin Property, which is prospective for gold and associated minerals. The Peak Gold JV Property is located in the Tetlin Hills and Mentasta Mountains of eastern interior Alaska. Its exploration projects are Lucky Shot, Johnson Tract, Eagle, Hona, Shamrock, and Triple Z.